Angioimmunoblastic T-cell lymphoma (AITL) represents an uncommon variant of T-cell lymphomas and most often presents insidiously with systemic symptoms. This report constitutes the first documented case of conjunctival AITL, masquerading as nodular episcleritis, and describes both the clinical and pathological findings. Furthermore, conjunctival T-cell lymphoma in general remains a rare occurrence, and a survey of previously reported cases reveals a wide variation in clinical presentation. A high index of suspicion, thorough examination and conjunctival biopsy are essential to reaching the diagnosis of conjunctival lymphoma.
Introduction
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive T-cell lymphoma subtype, accounting for 2% of all non-Hodgkin's lymphomas and 15-20% of all peripheral T-cell lymphomas [1] . Patients present with generalised lymphadenopathy, hepatosplenomegaly and cutaneous rashes, and the bone marrow is often involved at an early phase of the disease [1] . The aetiology is uncertain, but interestingly, over 75% of cases contain Epstein-Barr virus (EBV) within reactive B cells that are found amongst the neoplastic T-cell population [1] . It is an aggressive lymphoma, and patients often die of infectious complications. Some cases can also be complicated by the development of an EBV-driven high-grade B-cell lymphoma [1] .
Histologically, the key feature that distinguishes AITL from other peripheral T-cell lymphomas is the proliferation of high endothelial venules and follicular dendritic cells [1] . Conjunctival T-cell lymphoma is rare and more commonly secondary to systemic lymphoma [1] . In this case report, we detail the clinical and histopathological features of the first case of systemic AITL, presenting in the conjunctiva. The subject has given prior informed consent for this paper.
Case Description
A 72-year-old Caucasian male attended eye casualty with a 4-week history of painless enlarging lesions on his right eye. On examination, he had two pink, discrete, non-tender, bulbar conjunctival masses on his right eye ( fig. 1 a, b) . He was treated with prednisolone sodium phosphate drops (0.5%) for 8 weeks for presumed nodular episcleritis, but failed to demonstrate clinical improvement. Re-evaluation of the case raised the suspicion of conjunctival lymphoma, so the patient was referred to the local ocular oncology centre.
Seven months prior to his eye symptoms, the patient had been investigated for lethargy and night sweats. He had cervical lymphadenopathy, and blood tests revealed atypical lymphocytes, elevated lactate dehydrogenase of 528 IU/l (normal range 140-280 IU/l), polyclonal hypergammaglobulinaemia and a negative virus screen. A neck, thorax, abdomen and pelvis CT revealed bilateral cervical, axillary and groin lymphadenopathy with mild splenomegaly ( fig. 1 c) . A cervical lymph node core biopsy followed by cervical node excision biopsy showed identical histology. The lymph node excision biopsy showed a proliferation of high endothelial venules between which was a lymphoid infiltrate, effacing the lymph node architecture, comprising small-to medium-sized lymphocytes with scattered larger blast cells. These lymphoid cells were positive for CD3, CD4 and PD-1. Scattered CD20+, PD-1-negative, EBV-positive reactive B cells were seen in the background, and numerous CD21-positive follicular dendritic cells were identified. PCR detected T-cell receptor (TCR) rearrangements in the TCR gamma V-J region confirming T-cell monoclonal population. The constellation of high endothelial proliferation with a polymorphous T-cell infiltrate, prominent follicular dendritic cell proliferation with the presence of PD-1-positive T cells, EBV-positive reactive B cells and a T-cell clone all pointed to an unequivocal diagnosis of angioimmunoblastic T-cell lymphoma (AITL). Meanwhile, his symptoms spontaneously resolved with an interval CT scan demonstrating an absence of splenomegaly and regression of lymphadenopathy. His AITL was thought to be clinically indolent, and he was kept under observation only.
Given the AITL history, the nodules on the conjunctiva were thought to represent secondary AITL. Ultrasound biomicroscopy showed a uniform thickening of the conjunctiva ( fig. 1 d) without scleral invasion. Histology of an incisional biopsy of one of the conjunctival lesions showed a morphology consistent with a diagnosis of AITL. At low power, the conjunctival substantia propria was effaced by a diffuse mass ( fig. 1 node and conjunctival biopsy was CD10 expression by the lymphoma in the conjunctiva ( fig. 1 l) and not in the lymph node, and the presence of prominent CD21 follicular dendritic cells in the lymph node ( fig. 1 m) but not in the conjunctiva. Both CD10 and CD21 are classically expressed on the T cells and follicular dendritic cell networks, respectively, in AITL [1] . The conjunctival biopsy confirmed secondary involvement by systemic AITL. The patient was referred back to haematology for consideration of chemotherapy, but 5 weeks following the biopsy, the eye lesions had spontaneously regressed and treatment was deferred. 
Discussion
Primary and secondary conjunctival T-cell lymphomas are rare [2] . Retrobulbar neuritis secondary to systemic AITL has been reported [3] , but this case remains the first one of biopsy-proven conjunctival AITL (secondary).
The main clinical differential diagnoses in this case included conventional nodular episcleritis, paraneoplastic episcleritis and nodular scleritis. Nodular episcleritis presents with tender nodules to palpation with radial congested vessels running over them. Paraneoplastic episcleritis can occur as a phenomenon secondary to lymphoma without evidence of conjunctival secondaries [4] . However, in our case, the AITL nodules were painless and non- tender, and the vessels appeared obscured on the surface. Nodular scleritis is more painful than nodular episcleritis and associated with scleral oedema and systemic autoimmune conditions, features not seen in this case. Furthermore the presence of identical T-cell clones on PCR in different locations at different times strongly favoured lymphoma. A literature review of biopsy-proven conjunctival T-cell lymphoma revealed 11 documented cases, which are summarised in table 1 . Eight of these cases presented with an amelanotic conjunctival elevation, the majority (5/8) of which were located in the bulbar or forniceal conjunctiva, in keeping with the location of conjunctival lymphoma in general [5] . Five of the eight cases showed limbal and/or corneal changes varying from limbal thickening to frank keratitis and ulceration.
The main histological differential diagnosis from which AITL must be distinguished is angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) [1] , which shares considerable clinical and morphological features with AITL. Like AITL, it can present with lymphadenopathy, skin rashes, organomegaly and raised lactate dehydrogenase levels [1] . Histologically, AILD shows high endothelial venular proliferation with effacement of the lymph node architecture, an infiltrate of T cells similar to AITL, and also a prominent population of follicular dendritic cell networks [1] . However AILD does not show an aberrant expression of PD-1 or CD10, and most importantly does not display clonal T-cell receptor rearrangement, which is present in AITL [1] .
Spontaneous regression of systemic AITL without therapy is very rare, although it has been documented in a handful of publications [17] [18] [19] . Whilst this phenomenon is poorly understood, Schlegelberger et al. [19] showed that the presence of an extra third chromosome predicted a higher rate of spontaneous regression. We did not examine our case for this particular genetic change.
Our case highlights that new-onset conjunctival lesions mimicking nodular episcleritis in these patients may represent a recurrence of AITL. This should trigger a prompt conjunctival biopsy with expedited haematological review. Furthermore, a high index of suspicion should be maintained when dealing with cases of steroid refractory conjunctival nodules, and a thorough systems review and examination of adjacent structures such as the cornea may allude to a diagnosis of lymphoma.
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